Universidad Rey Juan Carlos-ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2019

  1. Fluoroscopic characterization of colonic dysmotility associated to opioid and cannabinoid agonists in conscious rats

    Journal of Neurogastroenterology and Motility, Vol. 25, Núm. 2, pp. 300-315

2018

  1. Preclinical evaluation of the effects on the gastrointestinal tract of the antineoplastic drug vincristine repeatedly administered to rats

    Neurogastroenterology and Motility, Vol. 30, Núm. 11

2017

  1. Caracterización fluoroscópica en rata de la dismotilidad colónica asociada a tratamiento con morfina

    Revista de la Sociedad Espanola del Dolor

  2. Computer vision-based diameter maps to study fluoroscopic recordings of small intestinal motility from conscious experimental animals

    Neurogastroenterology and Motility, Vol. 29, Núm. 8

  3. Involvement of cannabinoid signaling in vincristine-induced gastrointestinal dysmotility in the rat

    Frontiers in Pharmacology, Vol. 8, Núm. FEB

  4. May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat

    Neurogastroenterology and Motility, Vol. 29, Núm. 3

2015

  1. Effects of chronic dietary exposure to monosodium glutamate on feeding behavior, adiposity, gastrointestinal motility, and cardiovascular function in healthy adult rats

    Neurogastroenterology and Motility, Vol. 27, Núm. 11, pp. 1559-1570

  2. In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat

    Neurogastroenterology and Motility, Vol. 27, Núm. 12, pp. 1721-1735

  3. Valoración de actividades formativas de carácter trasversal en la Universidad Rey Juan Carlos (URJC): Seminarios sobre el cerebro

    Evaluación de la Calidad de la Investigación y de la Educación Superior: libro de resúmenes XI FECIES

2014

  1. X-ray analysis of the effect of the 5-HT3 receptor antagonist granisetron on gastrointestinal motility in rats repeatedly treated with the antitumoral drug cisplatin

    Experimental Brain Research, Vol. 232, Núm. 8, pp. 2601-2612

2013

  1. Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat

    Neurogastroenterology and Motility, Vol. 25, Núm. 5

2012

  1. The gastrointestinal pharmacology of cannabinoids: Focus on motility

    Pharmacology, Vol. 90, Núm. 1-2, pp. 1-10